SCHEMBL7778377

SCHEMBL7778377

CC(C)[C@@H](C(=O)O)N(CC(CN(C(=O)OCc1ccccc1)[C@H](C(=O)O)C(C)C)OCn1cnc2c(=O)[nH]c(N)nc21)C(=O)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3A Q14432 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
BLM P54132 2/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
CYP3A4 P08684 1/20 0.53
NFKB1 P19838 1/20 0.53
VCP P55072 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HIF1A Q16665 1/20 0.53
PNP P00491 6/20 0.48
HBB P68871 2/20 0.48
MAPK1 P28482 1/20 0.48
HPRT1 P00492 9/20 0.45
USP2 O75604 1/20 0.44
TSHR P16473 1/20 0.44
EDNRA P25101 1/20 0.44
HTR2A P28223 1/20 0.44
RECQL P46063 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4901757 0.88 MEN1 (0.57) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL7773468 0.87 PDE3A (0.55) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL10813642 0.82 BLM (0.62) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9414136 0.81 HPRT1 (0.54) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL7778380 0.80 HINT1 (0.40) PDE3AMEN1KMT2APNPHBB
SCHEMBL10812705 0.80 BLM (0.67) PDE3AMEN1KMT2ABLMALDH1A1
Ganciclovir SCHEMBL1241831 0.79 MEN1 (0.61) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9192475 0.78 PDE3A (0.60) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL9298573 0.78 PDE3A (0.60) PDE3AMEN1KMT2ABLMALDH1A1
SCHEMBL6839494 0.77 PDE3A (0.59) PDE3AMEN1KMT2ABLMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0877746-B1 PROCESS FOR PREPARING PURINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2001-09-19 EP disclosed
US-5700936-A Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate SYNTEX (U.S.A.) INC. (US) 1997-12-23 US disclosed
EP-0375329-B1 Antiviral pyrimidine and purine compounds, process for their preparation and pharmaceutical compositions containing them WELLCOME FOUND (GB) 1995-05-31 EP disclosed
US-5318974-A Amino acid esters of pyrimidine; used in the treatment of herpes virus infections BURROUGHS WELLCOME CO. (US) 1994-06-07 US disclosed